Katherine Stueland, GeneDx CEO, joins 'Closing Bell' to discuss company earnings and the future of genome sequencing.

A Texas-based lab is used by law enforcement in cases where local and state labs have failed to extract DNA from degraded or ...

GeneDx excels in comprehensive genome and exome testing using a vast genetic database linking 400+ diseases. See why I think ...

Edward Haynes reveals how advanced sequencing technologies are assisting food companies in their mission to deliver quality ...

From understanding hereditary diseases to predicting drug responses, sequencing helps researchers uncover the subtle language ...

The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions ...

In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...

The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...

President and CEO Katherine Stueland stated that GeneDx achieved significant milestones in 2024, including surpassing $95 million in Q4 revenue and expanding gross margins to 70%. She highlighted the ...

The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...

Illumina announces a new NGS-based spatial technology kit and new software platform, Illumina Connected Multiomics.

According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...